ClinicalTrials.Veeva

Menu
A

Advancing Vision Research, LLC | Smyrna, TN

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

AR-15512
AGN-190584
Bimatoprost
PL9643
AGN-242428
HL036
SAF312
Tanfanercept
AGN-193408
AGN-231868

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 19 total trials

A Study of TL-925 Ophthalmic Emulsion as a Treatment for Dry Eye Disease

In this prospective, phase 2b, multicenter, randomized, double-masked, vehicle-controlled, parallel-arm study, approximately 880 subjects with modera...

Active, not recruiting
Dry Eye Disease
Drug: TL-925
Other: Placebo

The purpose of this study is to evaluate the proportion of ocular adverse events reported in subjects with dry eye disease (DED) between the interven...

Enrolling
Dry Eye Disease
Drug: 0.003% AR-15512 ophthalmic solution
Drug: REFRESH® Classic ophthalmic solution

This is a multicenter, open-label, dose escalation (Cohort 1) to masked, randomized, parallel-groups (Cohort 2) and (Cohort 3) study to evaluate the...

Enrolling
Open-angle Glaucoma
Ocular Hypertension
Other: Sham Administration
Drug: AGN-193408 SR

The purpose of this study is to assess the safety and efficacy of FID 123320 Ophthalmic Solution compared to Vehicle for relieving redness of the eye...

Active, not recruiting
Ocular Redness
Eye Irritation
Drug: FID 123320 Ophthalmic Solution
Drug: Vehicle

This is a multi-center, double-masked, randomized, placebo-controlled, parallel-group, efficacy, safety, and tolerability study evaluating the effica...

Enrolling
Atopic Keratoconjunctivitis
Drug: Dupilumab

This study evaluates the duration of intraocular pressure (IOP)-lowering effect and safety of as needed administrations of Bimatoprost sustained rele...

Active, not recruiting
Open-Angle Glaucoma
Ocular Hypertension
Drug: Bimatoprost (SR)

This study will evaluate the long-term safety and efficacy of Bimatoprost Sustained Release (SR) in patients with open-angle glaucoma or ocular hyper...

Invitation-only
Open-Angle Glaucoma
Ocular Hypertension
Drug: Bimatoprost SR
Other: Standard of Care

Trial sponsors

Alcon logo
AbbVie logo
Allergan logo
Aerie Pharmaceuticals logo
Novartis logo
A
HanAll Biopharma logo
Kowa logo
P
T

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems